Faraz A. Choudhury, PhD is the president and CEO of Immuto Scientific. Dr. Choudhury co-founded Immuto Scientific in 2018 to commercialize a protein footprinting technology called Plasma Induced Modifications to Biomolecules (PLIMB) that was developed at the University of Wisconsin- Madison. Dr. Choudhury is one of the inventors of the PLIMB (Plasma Induced Modification to Biomolecules) technology and he has been involved in the design, development and application of the technology from the inception. His doctorate research work focused on developing plasma technologies for semiconductor manufacturing as well as biological applications. After completing his postdoctoral training, he worked several years as a Research Scientist in the Department of Biochemistry at the University of Wisconsin- Madison (UW Madison). His research focused on proteomics, epitope mapping and protein-­protein interactions studies using mass spectrometry.